Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
Hua Su, Ming Yang, Cheng Wan, Li-Xia Yi, Fang Tang, Hong-Yan Zhu, Fan Yi, Hai-Chun Yang, Agnes B Fogo, Xiu Nie, Chun Zhang, Hua Su, Ming Yang, Cheng Wan, Li-Xia Yi, Fang Tang, Hong-Yan Zhu, Fan Yi, Hai-Chun Yang, Agnes B Fogo, Xiu Nie, Chun Zhang
Abstract
Although the respiratory and immune systems are the major targets of Coronavirus Disease 2019 (COVID-19), acute kidney injury and proteinuria have also been observed. Currently, detailed pathologic examination of kidney damage in critically ill patients with COVID-19 has been lacking. To help define this we analyzed kidney abnormalities in 26 autopsies of patients with COVID-19 by light microscopy, ultrastructural observation and immunostaining. Patients were on average 69 years (19 male and 7 female) with respiratory failure associated with multiple organ dysfunction syndrome as the cause of death. Nine of the 26 showed clinical signs of kidney injury that included increased serum creatinine and/or new-onset proteinuria. By light microscopy, diffuse proximal tubule injury with the loss of brush border, non-isometric vacuolar degeneration, and even frank necrosis was observed. Occasional hemosiderin granules and pigmented casts were identified. There were prominent erythrocyte aggregates obstructing the lumen of capillaries without platelet or fibrinoid material. Evidence of vasculitis, interstitial inflammation or hemorrhage was absent. Electron microscopic examination showed clusters of coronavirus-like particles with distinctive spikes in the tubular epithelium and podocytes. Furthermore, the receptor of SARS-CoV-2, ACE2 was found to be upregulated in patients with COVID-19, and immunostaining with SARS-CoV nucleoprotein antibody was positive in tubules. In addition to the direct virulence of SARS-CoV-2, factors contributing to acute kidney injury included systemic hypoxia, abnormal coagulation, and possible drug or hyperventilation-relevant rhabdomyolysis. Thus, our studies provide direct evidence of the invasion of SARSCoV-2 into kidney tissue. These findings will greatly add to the current understanding of SARS-CoV-2 infection.
Keywords: COVID-19; SARS-CoV-2; acute kidney injury; proteinuria; renal pathology.
Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Figures
References
- Lu R., Zhao X., Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574.
- Guan W.J., Ni Z.Y., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
- Alsaad K.O., Hajeer A.H., Al Balwi M. Histopathology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection—clinicopathological and ultrastructural study. Histopathology. 2018;72:516–524.
- Xu Z., Shi L., Wang Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422.
- Tietäväinen J., Mantula P., Outinen T. Glucosuria predicts the severity of Puumala hantavirus infection. Kidney Int Rep. 2019;4:1296–1303.
- Falk R.J., Jennette J.C. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8:314–322.
- Zhou P., Yang X.L., Wang X.G. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273.
- Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection [e-pub ahead of print]. Biochem Biophys Res Commun. doi:. Accessed March 28, 2020.
- Santos R.A.S., Sampaio W.O., Alzamora A.C. The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7) Physiol Rev. 2018;98:505–553.
- Mizuiri S., Ohashi Y. ACE and ACE2 in kidney disease. World J Nephrol. 2015;4:74–82.
- Lee S.H., Lee Y.H., Jung S.W. Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats. Am J Physiol Renal Physiol. 2019;317:F670–F682.
- Wang K, Chen W, Zhou YS, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. doi:. Accessed March 28, 2020.
- Tanaka Y., Sato Y., Sasaki T. Suppression of coronavirus replication by cyclophilin inhibitors. Viruses. 2013;5:1250–1260.
- de Wilde A.H., Raj V.S., Oudshoorn D. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment. J Gen Virol. 2013;94:1749–1760.
Source: PubMed